Westminster Forum Projects is hosting an online webinar to discuss the optimisation of diagnostics for improved speed and outcomes. Also being discussed will be the future outlook for medical device regulation in the wake of Brexit, with the MHRA having consulted on a more transparent and flexible approach.
BIVDA Chief Executive Doris-Ann Williams will be among the main speakers at this event. She will be discussing the advancement of diagnostic activity in the UK, and opportunities for industry collaboration, among other subjects.
Additional areas for discussion include staff recruitment and retention, learnings from COVID-19 and opportunities for enhanced efficiencies.
Stakeholders with key policy officials are due to attend from BEIS; the DHSC; the Department of Health, NI; the DIT; the MHRA; Government Office for Science; the OLS; the UKHSA; The Scottish Government; and the Welsh Government – as well as parliamentary pass-holders from both Houses of Parliament.
Please register your attendance and book a place at the event here.
Keynote sessions will be held with the following speakers:
- Professor Sir Mark Caulfield, Professor of Clinical Pharmacology, Queen Mary University of London; Chief Executive Officer, Barts Life Sciences; and former Chief Scientist, Genomics England
- Dr Sarah Byron, Programme Director, Centre for Health Technology Evaluation, NICE
- Doris-Ann Williams, Chief Executive, British In Vitro Diagnostics Association
- Professor Michael Messenger, Principal Scientific Advisor for In Vitro Diagnostics, MHRA
- Professor Louise Jones, Chair, Genomics and Reproductive Science Specialty Advisory Committee, Royal College of Pathologists; and Professor of Breast Pathology, Barts Cancer Institute
- Stephen Lee, Director, Diagnostics Regulation, Association of British Healthcare Industries
